Christen Russell
Optometrist · Jacksonville, FLNPI 1538391032
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $271 and has fallen 58.9% since, to $111 in 2025.
Across 37 payments — averaging $33.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$284
- Johnson & Johnson Vision Care, Inc.$205
- Kala Pharmaceuticals, Inc.$142
- Alcon$109
- Coopervision Inc.$69
- Bausch & Lomb, A Division Of Bausch Health US, LLC$58
- plus $390 from 11 others
What the payments were for
- Food & beverage$1,19495%
- Education$181%
- Entertainment$433%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Simplicity$266
- Acuvue$120
How this compares
$1,255 in reported general payments places this provider in the 55th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $185 |
| Latanoprost | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Jacksonville
- Brett O'ConnorJacksonville$91K
- Jon WalkerJacksonville$65K
- Anthony FavaleJacksonville$35K
- Kimberly RiordanJacksonville$23K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.